Table 2.
Drug Use in 2424 Patients with Crohn’s Disease in Taiwan.
| With perianal disease | Without perianal disease | P-value | |
|---|---|---|---|
| N (%) | N (%) | ||
| Total | 358 (100.0) | 2066 (100.0) | |
| Medication | |||
| 5-ASA | 336 (93.9) | 1412 (68.3) | <.01 |
| Steroid | 336 (93.9) | 1796 (86.9) | <.01 |
| Azathioprine | 221 (61.7) | 629 (30.4) | <.01 |
| Anti-TNF-alpha | 159 (44.4) | 316 (15.3) | <.01 |
| Vedolizumab | 7 (2.0) | 3 (0.1) | <.01 |
| Antibiotics | 286 (79.9) | 1,117 (54.1) | <.01 |
| Metronidazole | 266 (74.3) | 907 (43.9) | <.01 |
| Ciprofloxacin | 167 (46.6) | 572 (27.7) | <.01 |
5-ASA: 5-aminosalicyclic acid; TNF: tumor necrosis factor.